Home/Filings/4/0001628280-24-000282
4//SEC Filing

Sandler Alan B. 4

Accession 0001628280-24-000282

CIK 0001576263other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 6:01 PM ET

Size

4.7 KB

Accession

0001628280-24-000282

Insider Transaction Report

Form 4
Period: 2023-12-29
Sandler Alan B.
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2023-12-29$58.75/sh+17,021$999,98479,318 total
Footnotes (1)
  • [F1]Grant of Restricted Stock Units (RSUs). Shares will vest 25% annually on the anniversary of the grant date until fully vested.

Issuer

Mirati Therapeutics, Inc.

CIK 0001576263

Entity typeother

Related Parties

1
  • filerCIK 0001835966

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 6:01 PM ET
Size
4.7 KB